F2 and autoimmune hepatitis: While overall results across all etiologies were neutral, a subgroup analysis in HBV and autoimmune hepatitis patients revealed a significantly improved prothrombin slope (p = 0.04) and a reduction in hospitalization duration (8 vs. 14 days, p = 0.02).